
Advances in the application of the glymphatic system for amyloid-beta clearanc
Jiayi LI, Zhongyue LYU, Hao WU, Xiao CHEN, Fan FU, Kaixia YANG, Guomin XIE
Chinese Journal of Alzheimer's Disease and Related Disorders ›› 2025, Vol. 8 ›› Issue (3) : 188-193.
Abbreviation (ISO4): Chinese Journal of Alzheimer's Disease and Related Disorders
Editor in chief: Jun WANG
Advances in the application of the glymphatic system for amyloid-beta clearanc
Alzheimer's disease (AD) is the most common neurodegenerative disease worldwide and a leading cause of dementia. Currently, there are no highly effective treatments for this condition. The imbalance between the production and clearance of Aβ(amyloid-beta) protein is considered a primary pathogenic mechanism of AD. Enhancing the clearance of Aβ in the brain during the early stages can delay the onset and progression of AD. In recent years, with the introduction of the concept of the glymphatic system and the discovery of meningeal lymphatic vessels, the directional transport of fluids within the central nervous system has become a research hotspot. The glymphatic system plays a crucial role in clearing amyloid-beta protein and holds promise as a novel approach to combat neurodegenerative diseases. This review aims to summarize the current research progress on the role of the brain's glymphatic system in AD treatment and explore its potential applications in disease management.
Alzheimer's disease / Amyloid-beta / Glymphatic system / Neurodegenerative diseases / Aging
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
|
[32] |
|
[33] |
|
[34] |
|
[35] |
陈泽然, 黄梦颖, 曾利川, 等. 应用于人脑胶质淋巴系统的磁共振成像技术研究进展[J]. 中国全科医学, 2024, 27(26): 3314-3319.
|
[36] |
|
[37] |
|
[38] |
|
[39] |
杜晓岚, 段曦瑞, 李国臣, 等. 磁共振成像技术在人脑胶质淋巴系统研究的现状与挑战[J]. 磁共振成像, 2024, 15(11): 180-184.
|
[40] |
|
[41] |
|
[42] |
|
[43] |
|
[44] |
|
[45] |
|
/
〈 |
|
〉 |